Navigation Links
Unpublished trial data 'violates an ethical obligation' to study participants, say researchers
Date:10/29/2013

Almost one in three (29%) large clinical trials remain unpublished five years after completion. And of these, 78% have no results publicly available, finds a study published on bmj.com today.

This means that an estimated 250,000 people have been exposed to the risks of trial participation without the societal benefits that accompany the dissemination of their results, say the authors.

They argue that this "violates an ethical obligation that investigators have towards study participants" and call for additional safeguards "to ensure timely public dissemination of trial data."

Randomized clinical trials are a critical means of advancing medical knowledge. They depend on the willingness of people to expose themselves to risks, but the ethical justification for these risks is that society will eventually benefit from the knowledge gained from the trial.

But when trial data remain unpublished, the societal benefit that may have motivated someone to enrol in a study remains unrealized.

US law requires that many trials involving human participants be registered - and their results posted - on the largest clinical trial website ClinicalTrials.gov. But evidence suggests that this legislation has been largely ignored.

So a team of US-based researchers set out to estimate the frequency of non-publication of trial results and, among unpublished studies, the frequency with which results are unavailable in the ClinicalTrials.gov database.

They searched scientific literature databases and identified 585 trials with at least 500 participants that were registered with ClinicalTrials.gov and completed prior to January 2009. The average time between study completion and the final literature search (November 2012) was 60 m
'/>"/>

Contact: Stephanie Burns
sburns@bmj.com
44-020-738-36920
BMJ-British Medical Journal
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Brain Tumor Vaccine Shows Promise in Early Trial
2. URMC clinical trial tests new regimen for hypertension
3. Analysis Finds Clinical Trials Often Small, of Poor Quality
4. US spends far more for health care than 12 industrialized nations, but quality varies
5. New Weight-Loss Drug Shows Promise in Trial
6. Palpitations are predictive of future atrial fibrillation
7. Trial Set to See if Drug Can Prevent Alzheimers
8. Experts call for clinical trials to test non-skeletal benefits of vitamin D
9. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
10. Canada should significantly increase its funding of randomized clinical trials
11. Alzheimers vaccine trial a success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, CARE ... journey from a treasured member of the CARE extended family. , By shedding ... help intended parents across the globe gain a newfound perspective on surrogacy in Mexico. ...
(Date:7/29/2015)... ... July 29, 2015 , ... Andrzej Klos, M.D., has been reviewed and approved ... nearly 38 years, is motivated each and every day by his sincere desire to ... alongside his many awards and accolades, which include multiple listings in many highly regarded ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Potomac Pilates, ... rebrand, changing its name to Rock the Reformer ® by Potomac Pilates. On ... http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue to offer ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a reliable source of ... vs. USA . , The international soccer schedule of matches played on American ... on September 8th, one of the world’s greatest teams, Brazil, will travel to North ...
(Date:7/29/2015)... , ... July 29, 2015 , ... This year, the ... precipitation levels this spring. And, where there is water, mold is not far behind. ... offers tips for protecting against water and mold damage. Paul Davis is regularly called ...
Breaking Medicine News(10 mins):Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3
... The Northwestern Medical,Faculty Foundation (NMFF) will supply radiation ... Northern Illinois Proton Treatment,and Research Center (NIPTRC), according ... today., NIPTRC, which is under construction 30 ... Park, will be a world-class, state-of-the-art,proton cancer treatment ...
... WHAT: ,An international study showed testosterone, when used with no ... libido in postmenopausal women. More than 800 women from ... United Kingdom and Sweden participated in the study, the ... patch can boost sex drive in postmenopausal women. ...
... WHAT:,The Fifth International Conference on Cell Therapy for ... dedicated to the evolving field of cell-based therapies ... year,s meeting is "Cellular and Molecular Building Blocks: ... in the field will convene to present basic, ...
... a Focus on Fun, FORT WORTH, Texas, Nov. ... program for girls and boys between the,ages of 3 ... of Fort Worth SW. With an,emphasis on fun, team-building ... of cheerleading, including sideline,cheers and chants, stunts and routines. ...
... son, Julian, had a brain tumor the size of a golf ball. ... was diagnosed with the same rare form of cancer, called medulloblastoma. Before ... stage III Rhabdomyosarcoma, a very aggressive soft muscle tumor. , ... ...
... Results and Physician Expertise Most Important, ... new study,conducted by the American Society for ... of sanofi-aventis U.S. LLC, reveals the,influencers that ... treatments. The study surveyed women ages 35-69 ...
Cached Medicine News:Health News:Northwestern Medical Faculty Foundation Signs Long-Term Agreement to be the Provider of Doctors for Northern Illinois Proton Treatment and Research Center 2Health News:Northwestern Medical Faculty Foundation Signs Long-Term Agreement to be the Provider of Doctors for Northern Illinois Proton Treatment and Research Center 3Health News:5th Annual Global Conference on Stem Cell Therapy to be held Jan. 13-16, 2009 in NYC 2Health News:The Little Gym of Fort Worth SW Introduces Kids' Cheerleading Program 2Health News: Three Women in Health Crises Go Online to Form Lifelong Friendships : Mothers of Boys with Cancer Find Support, Encouragement and Each Other at CarePages.com 2Health News: Three Women in Health Crises Go Online to Form Lifelong Friendships : Mothers of Boys with Cancer Find Support, Encouragement and Each Other at CarePages.com 3Health News:New Study Reveals What Women Want When Considering Cosmetic Procedures 2
(Date:7/29/2015)... , July 29, 2015  Depomed, Inc. (NASDAQ: ... announced that its Board of Directors, after careful ... financial and legal advisors, has unanimously rejected the ... from Horizon Pharma plc (NASDAQ: HZNP ) ... of Depomed in an all-stock transaction (the "July ...
(Date:7/29/2015)... Uno studio clinico di un centro ... probiotico L. reuteri di Nutraceutix arricchisce ... intestinale di fattori proteici che aumentano la secrezione ... ceppo di L. reuteri di Nutraceutix ... di somministrazione brevettato BIO- tract ® che protegge ...
(Date:7/29/2015)... 2015   KaloBios Pharmaceuticals, Inc . (Nasdaq: ... innovative therapies to benefit patients with diseases of unmet ... that the U.S. Food and Drug Administration (FDA) has ... KB003, an anti-GM-CSF monoclonal antibody (mAb), in patients with ... now active. The acceptance of this IND ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5
... Delivery System Has Potential to, Help Solve Radiation Therapy Access and ... ... Symposium, WASHINGTON, Sept. 8 Early clinical experience with the,FDA ... non-isotopic treatment is a viable,option for adjuvant therapy for early-stage breast ...
... Compared to FISH ... - Company to Include Reporting for HER2 Gene Expression in All Oncotype DX ... Reports by End ... GHDX ) today announced results from two studies demonstrating,that quantitative reporting for ...
Cached Medicine Technology:Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 2Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 3Electronic Brachytherapy a Viable Option for Early Stage Breast Cancer, According to Study Presented at ASCO Breast Cancer Symposium 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5
... 694,000 x g at speeds ... Coulter's Optima L-90K Ultracentrifuge enables ... in less time. This versatile ... broad range of superb rotors, ...
... Ultracentrifuge power for small-volume samples. With the ... of removing chylomicrons (fat particles in lipemic ... for lipemic clarification. Lipemic samples can be ... for sendouts. The easy-to-operate tabletop centrifuge: ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
... The ADVIA 2400 Chemistry System pushes ... the reliability and stability that keep ... 2-second probe cycle time maximizes tube ... with the systems efficient automation-readiness, gives ...
Medicine Products: